Opens in a new tab

Dr. Chen Minshan

Chinese name: 陈敏山
Chief Physician, Professor, Doctoral Supervisor, Chief Expert in Liver Cancer . Hepatobiliary Surgery
Dr. Chen Minshan is Director of Hepatobiliary Surgery and Director of the Liver Cancer Institute at Sun Yat-sen University Cancer Center, a chief expert in liver cancer. He has more than 30 years of experience and is a leading authority on multidisciplinary treatment, ablation and surgical resection of liver cancer.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+ years
Clinical experience
3,000+ cases
Liver surgeries and ablations
400+ papers
Academic output

  • The Physician

About Dr. Chen Minshan

Dr. Chen Minshan is Director of Hepatobiliary Surgery at Sun Yat-sen University Cancer Center and Director of the Sun Yat-sen University Liver Cancer Institute. A professor, chief physician and doctoral supervisor with over 30 years of experience, he specializes in the multidisciplinary treatment of liver cancer, including surgical resection, radiofrequency ablation and interventional therapy. He published 405 papers and led the first international randomized trial comparing ablation with surgery for small liver cancer. His findings have been cited by the US NCCN liver cancer guidelines for six consecutive years, and he won the Guangdong Provincial Science and Technology First Prize.
1、Director of Hepatobiliary Surgery at Sun Yat-sen University Cancer Center and Director of the Sun Yat-sen University Liver Cancer Institute
2、Chief expert in liver cancer; professor, chief physician and doctoral supervisor with over 30 years of experience
3、Chairman of the CACA Liver Cancer Committee and Vice Chairman of the CSCO Liver Cancer Expert Committee
4、Published 405 papers on liver cancer and led the first international randomized trial of ablation versus surgery for small liver cancer
5、Research cited by the US NCCN liver cancer guidelines for six consecutive years and Elsevier China Highly Cited Researcher for eight consecutive years
6、Won the Guangdong Provincial Science and Technology First Prize and named among China’s Top 10 Liver Tumor Surgeons for four consecutive years

Dr. Chen Minshan ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Primary liver cancer

Multidisciplinary treatment combining surgery, ablation and interventional therapy; he led the first randomized trial comparing radiofrequency ablation with surgical resection for small liver cancer, a landmark study cited more than 1,500 times and guiding treatment choices for patients with early-stage tumors.

Unresectable liver cancer

Transarterial chemoembolization combined with thermal ablation and systemic therapy; his phase 3 trials optimize conversion and combination strategies for patients initially unsuitable for surgery, helping more patients become eligible for curative resection and improving overall outcomes and survival in advanced disease.

Liver cancer ablation

Standardized local ablation therapy; he drafted China's expert consensus on standardized local ablation for liver cancer and has extensive experience in radiofrequency and microwave ablation of liver tumors, offering minimally invasive, effective treatment options for patients who cannot undergo open surgery.

More: hepatobiliary tumors, liver metastases, and multidisciplinary diagnosis and treatment of complex liver cancer

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Radiofrequency Ablation versus Surgical Resection for Small Hepatocellular Carcinoma: A Randomized Trial
This landmark randomized trial enrolled 180 patients with a solitary hepatocellular carcinoma no larger than 5 cm, comparing percutaneous radiofrequency ablation with partial hepatectomy. Overall survival proved comparable between the two arms, while ablation caused fewer severe complications. The findings help patients with small liver tumors choose a minimally invasive alternative to open liver surgery.
2. Sequential TACE Combined with Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma
This prospective randomized trial treated 139 patients with recurrent hepatocellular carcinoma measuring 5 cm or smaller. Sequential transcatheter arterial chemoembolization followed by radiofrequency ablation achieved significantly better overall and recurrence-free survival than ablation alone. The combined approach offers a liver-directed treatment option for patients whose liver cancer returns after initial curative therapy.
3. Radiofrequency Ablation With or Without Transcatheter Arterial Chemoembolization for Hepatocellular Carcinoma
This randomized trial assigned 189 patients with hepatocellular carcinoma smaller than 7 cm to radiofrequency ablation plus chemoembolization or ablation alone. Combining the two therapies significantly improved overall survival. The strategy supports patients with intermediate-sized liver tumors or those unsuitable for surgical resection who seek effective tumor control.
4. Long-Term Outcomes of Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation for Early-Stage Hepatocellular Carcinoma
This long-term follow-up study evaluated 189 patients with early-stage hepatocellular carcinoma treated initially with chemoembolization plus radiofrequency ablation versus ablation alone. The combination produced superior five- and seven-year overall survival. The results inform patients with early liver cancer, including those with cirrhosis, about durable outcomes from combined image-guided locoregional treatment.
5. Radiofrequency Ablation for Small Hepatocellular Carcinoma: A Clinical Guide
This clinical book presents practical methods for treating small hepatocellular carcinoma with radiofrequency ablation, covering patient selection, imaging guidance, procedural technique, complication management, and combined therapies with chemoembolization. Written by liver cancer specialists, it helps patients and clinicians understand a minimally invasive, image-guided option for small liver tumors that preserves healthy liver tissue.
6. Multidisciplinary Team Management for Liver Cancer at Sun Yat-sen University Cancer Center
Professor Minshan Chen leads an experienced multidisciplinary team for the diagnosis and treatment of liver cancer, integrating surgery, ablation, chemoembolization, targeted therapy, and immunotherapy. This coordinated approach tailors care for patients with hepatocellular carcinoma, including complex or recurrent tumors, and guides international patients seeking expert liver cancer consultations and individualized treatment planning.
  • Affiliated Hospital

Where Dr. Chen Minshan practices

Guangzhou

Sun Yat-sen University Cancer Center

Chinese name: 中山大学肿瘤防治中心
Sun Yat-sen University Cancer Center, founded in 1964, is South China's leading oncology institute and the nation's top-ranked cancer center in scientific impact, ranking fifth worldwide on the 2024 Nature Index, with 6 academicians and one of Asia's finest radiotherapy centers.
Since 1964
62 years of cancer care
2,245
Licensed beds
2.56 million
Annual outpatient visits
6
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Chen Minshan?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Chen Minshan.